Your browser doesn't support javascript.
loading
Effects of infliximab on brain neurochemistry of adults with bipolar depression.
Mansur, Rodrigo B; Subramaniapillai, Mehala; Lee, Yena; Pan, Zihang; Carmona, Nicole E; Shekotikhina, Margarita; Iacobucci, Michelle; Rodrigues, Nelson; Nasri, Flora; Rosenblat, Joshua D; Brietzke, Elisa; Cosgrove, Victoria E; Kramer, Nicole E; Suppes, Trisha; Newport, Jason; Hajek, Tomas; McIntyre, Roger S.
Afiliación
  • Mansur RB; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Subramaniapillai M; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Lee Y; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Pan Z; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Carmona NE; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychology, Ryerson University, Toronto, ON, Canada.
  • Shekotikhina M; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; University of Ottawa, Department of Psychiatry, Ottawa, ON, Canada.
  • Iacobucci M; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Rodrigues N; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Nasri F; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Rosenblat JD; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Brietzke E; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Kingston General Hospital, Providence Care Hospital, Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada.
  • Cosgrove VE; Department of Psychiatry & Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, CA, USA.
  • Kramer NE; Department of Psychiatry & Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, CA, USA.
  • Suppes T; Department of Psychiatry & Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, CA, USA; VA Palo Alto Health Care System, Palo Alto, CA, USA.
  • Newport J; Department of Psychiatry, Dalhousie University, Halifax, Canada.
  • Hajek T; Department of Psychiatry, Dalhousie University, Halifax, Canada.
  • McIntyre RS; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
J Affect Disord ; 281: 61-66, 2021 02 15.
Article en En | MEDLINE | ID: mdl-33296798
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Bipolar / Neuroquímica Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Affect Disord Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Bipolar / Neuroquímica Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Affect Disord Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Países Bajos